Page last updated: 2024-09-03

cyclo(7-aminoheptanoylphenylalanyl-tryptophyl-lysyl-benzylthreonyl) and Atrophy

cyclo(7-aminoheptanoylphenylalanyl-tryptophyl-lysyl-benzylthreonyl) has been researched along with Atrophy in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Belloni, AS; Markowska, A; Mazzocchi, G; Musajo, FG; Nussdorfer, GG; Rebuffat, P; Rocco, S1

Other Studies

1 other study(ies) available for cyclo(7-aminoheptanoylphenylalanyl-tryptophyl-lysyl-benzylthreonyl) and Atrophy

ArticleYear
Evidence that endogenous somatostatin (SRIF) exerts an inhibitory control on the function and growth of rat adrenal zona glomerulosa. The possible involvement of zona medullaris as a source of endogenous SRIF.
    The Journal of steroid biochemistry and molecular biology, 1994, Volume: 48, Issue:4

    Topics: Adrenal Cortex; Adrenalectomy; Adrenocorticotropic Hormone; Aldosterone; Angiotensin II; Animals; Atrophy; Hypertrophy; Male; Rats; Rats, Wistar; Somatostatin; Zona Glomerulosa

1994